Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-?B-NLRP3 Inflammasome Signaling Pathway için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Avanafil as a Novel Therapeutic Agent Against LPS-Induced Acute Lung Injury via Increasing CGMP to Downregulate the TLR4-NF-?B-NLRP3 Inflammasome Signaling Pathway | 9 |
Aylık toplam ziyaret
| views | |
|---|---|
| Şubat 2026 | 3 |
| Mart 2026 | 1 |
| Nisan 2026 | 0 |
| Mayıs 2026 | 0 |
| Haziran 2026 | 1 |
| Temmuz 2026 | 1 |
| Ağustos 2026 | 0 |
